Femasys appoints John Moorhead to board; director Eichenbaum resigns October 30, 2026
Femasys reported that director Kenneth Eichenbaum resigned effective October 30, 2026, after Pointillist ended its right to nominate a board member, and that John Moorhead was appointed to the board the same day as a designee of Nantahala Capital Management, the Lead Investor. The filing says Dr. Eichenbaum's resignation was not due to any dispute with the company, and Mr. Moorhead will serve on the Audit and Compensation Committees.
Key points
- Kenneth D. Eichenbaum resigned as a director effective October 30, 2026, tied to Pointillist Global Macro Series ending its nomination right under the November 3, 2025 Securities Purchase Agreement
- John Moorhead appointed director October 30, 2026 as a designee under an August 7, 2026 side letter with Nantahala Capital Management; he holds a Class II seat expiring at the 2029 annual meeting
- Board determined Mr. Moorhead is independent under Nasdaq rules and will serve on the Audit and Compensation Committees
- Company issued a press release on October 30, 2026 announcing the appointment (Exhibit 99.1)
The filing
Written by AI on Nov 9, 2026, 8:36 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on November 02, 2026.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.